Exact Mass: 711.3607

Exact Mass Matches: 711.3607

Found 60 metabolites which its exact mass value is equals to given mass value 711.3607, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Indinavir Sulfate

Indinavir Sulfate

C36H49N5O8S (711.3302)


D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

Ipamorelin

6-amino-2-(2-{2-[2-(2-amino-2-methylpropanamido)-3-(3H-imidazol-4-yl)propanamido]-3-(naphthalen-2-yl)propanamido}-3-phenylpropanamido)hexanamide

C38H49N9O5 (711.3856)


   
   

Daphcalycinosidine C

Daphcalycinosidine C

C38H49NO12 (711.3255)


   
   
   
   

cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)

cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)

C43H63FeNP2 (711.3785)


   

Tris(dipivaloylmethanato)terbium

Tris(dipivaloylmethanato)terbium

C33H60O6Tb (711.3643)


   

Dynorphin A (1-6)

Dynorphin A (1-6)

C34H49N9O8 (711.3704)


   

Ipamorelin

H-Aib-DL-His-DL-2Nal-DL-Phe-DL-Lys-NH2

C38H49N9O5 (711.3856)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76358 - Growth Hormone-Releasing Hormone Analogue

   

(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane

(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane

C43H63FeNP2 (711.3785)


   

6-O-methyl-28-dehydroxydamavaricin C

6-O-methyl-28-dehydroxydamavaricin C

C38H49NO12 (711.3255)


   

1-[(3S,9R,10R)-12-[(2S)-1-(dimethylamino)propan-2-yl]-9-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea

1-[(3S,9R,10R)-12-[(2S)-1-(dimethylamino)propan-2-yl]-9-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea

C37H50FN5O6S (711.3466)


   

ATTO 425 biotin derivative

ATTO 425 biotin derivative

C37H53N5O7S (711.3666)


   

Ac-Gln-D-Phe-His-D-Pro-betaAla-betaAla

Ac-Gln-D-Phe-His-D-Pro-betaAla-betaAla

C33H45N9O9 (711.334)


   

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

N-(2-aminophenyl)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

N-(2-aminophenyl)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide

C38H48F3N5O5 (711.3607)


   

phosphatidylinositol 25:0(1-)

phosphatidylinositol 25:0(1-)

C34H64O13P (711.4084)


A 1-phosphatidyl-1D-myo-inositol(1-) in which the two phosphatidyl acyl groups contain a total of 25 carbons and are fully saturated.

   
   
   
   
   
   
   
   
   
   
   
   
   
   

ST 28:3;O8;HexNAc

ST 28:3;O8;HexNAc

C36H57NO13 (711.383)


   

LCKLSL (hydrochloride)

LCKLSL (hydrochloride)

C30H58ClN7O8S (711.3756)


LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL hydrochloride potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL hydrochloride also inhibits the generation of plasmin and has anti-angiogenic roles[1].

   

19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

C43H53NO8 (711.3771)


   

1-{[6-({2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

1-{[6-({2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C38H49NO12 (711.3255)


   

(?)-2α-acetoxy-2',7-dideacetoxy-1-hydroxy-11(15→1)-abeo-austrospicatine

NA

C39H53NO11 (711.3618)


{"Ingredient_id": "HBIN005259","Ingredient_name": "(?)-2\u03b1-acetoxy-2',7-dideacetoxy-1-hydroxy-11(15\u21921)-abeo-austrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(+)-2alpha-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine

(+)-2α-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine

C39H53NO11 (711.3618)


{"Ingredient_id": "HBIN005260","Ingredient_name": "(+)-2alpha-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine","Alias": "(+)-2\u03b1-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)OC(=O)CC(C4=CC=CC=C4)N(C)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "711.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25404;158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5320472","DrugBank_id": "NA"}

   

2alpha-hydroxy-2'beta-deacetylaustrospicatine

2α-hydroxy-2'β-deacetylaustrospicatine

C39H53NO11 (711.3618)


{"Ingredient_id": "HBIN005282","Ingredient_name": "2alpha-hydroxy-2'beta-deacetylaustrospicatine","Alias": "2\u03b1-hydroxy-2'\u03b2-deacetylaustrospicatine","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31173;9958","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2'-deacetylaustrospicatine

NA

C39H53NO11 (711.3618)


{"Ingredient_id": "HBIN005503","Ingredient_name": "2'-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4717","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7beta-deacetylaustrospicatine

NA

C39H53NO11 (711.3618)


{"Ingredient_id": "HBIN013099","Ingredient_name": "7beta-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C2(C)C)CC1OC(=O)C)C(=C)C(CC3O)OC(=O)C(C(C4=CC=CC=C4)N(C)C)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26034","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-deacetylaustrospicatine

NA

C39H53NO11 (711.3618)


{"Ingredient_id": "HBIN013142","Ingredient_name": "7-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4718","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-12-ethyl-1,3,5,6,25-pentahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-12-ethyl-1,3,5,6,25-pentahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

C35H53NO14 (711.3466)


   

(2s,3as,4s,4ar,6s,8ar,9r,10r)-2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl (3r)-3-(dimethylamino)-3-phenylpropanoate

(2s,3as,4s,4ar,6s,8ar,9r,10r)-2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl (3r)-3-(dimethylamino)-3-phenylpropanoate

C39H53NO11 (711.3618)


   

2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl 3-(dimethylamino)-3-phenylpropanoate

2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl 3-(dimethylamino)-3-phenylpropanoate

C39H53NO11 (711.3618)


   

(2s,3s,3as,4r,6s,7s,8s,12r,13ar)-7-(acetyloxy)-4,12,13a-trihydroxy-2,9,9,12-tetramethyl-3,6-bis({[(2z)-2-methylbut-2-enoyl]oxy})-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

(2s,3s,3as,4r,6s,7s,8s,12r,13ar)-7-(acetyloxy)-4,12,13a-trihydroxy-2,9,9,12-tetramethyl-3,6-bis({[(2z)-2-methylbut-2-enoyl]oxy})-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

C38H49NO12 (711.3255)


   

(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-6-{[(1r,2s,3r,5r,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-6-{[(1r,2s,3r,5r,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C38H49NO12 (711.3255)


   

(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one

C43H53NO8 (711.3771)


   

(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-6-{[(1r,2s,3r,5s,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-6-{[(1r,2s,3r,5s,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid

C38H49NO12 (711.3255)


   

7-(acetyloxy)-4,12,13a-trihydroxy-2,9,9,12-tetramethyl-3,6-bis[(2-methylbut-2-enoyl)oxy]-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

7-(acetyloxy)-4,12,13a-trihydroxy-2,9,9,12-tetramethyl-3,6-bis[(2-methylbut-2-enoyl)oxy]-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate

C38H49NO12 (711.3255)


   

3-[(2s,5s,11s,14s)-5,11,14-tribenzyl-6,9,15,18-tetrahydroxy-4,13-dimethyl-3,12-dioxo-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),6,9,15-tetraen-2-yl]propanimidic acid

3-[(2s,5s,11s,14s)-5,11,14-tribenzyl-6,9,15,18-tetrahydroxy-4,13-dimethyl-3,12-dioxo-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),6,9,15-tetraen-2-yl]propanimidic acid

C38H45N7O7 (711.338)


   

(7e,13e,15e,17e,19e)-21-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-12-ethyl-1,3,5,6,25-pentahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

(7e,13e,15e,17e,19e)-21-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-12-ethyl-1,3,5,6,25-pentahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid

C35H53NO14 (711.3466)


   

(3s,9s,12r,18s,21s,24s)-18-benzyl-21-[(2s)-butan-2-yl]-11,14,17,20,23-pentahydroxy-12-(hydroxymethyl)-9-(2-methylpropyl)-1,7,10,13,16,19,22-heptaazatricyclo[22.3.0.0³,⁷]heptacosa-10,13,16,19,22-pentaene-2,8-dione

(3s,9s,12r,18s,21s,24s)-18-benzyl-21-[(2s)-butan-2-yl]-11,14,17,20,23-pentahydroxy-12-(hydroxymethyl)-9-(2-methylpropyl)-1,7,10,13,16,19,22-heptaazatricyclo[22.3.0.0³,⁷]heptacosa-10,13,16,19,22-pentaene-2,8-dione

C36H53N7O8 (711.3955)


   

3-[5,11,14-tribenzyl-6,9,15,18-tetrahydroxy-4,13-dimethyl-3,12-dioxo-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),6,9,15-tetraen-2-yl]propanimidic acid

3-[5,11,14-tribenzyl-6,9,15,18-tetrahydroxy-4,13-dimethyl-3,12-dioxo-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),6,9,15-tetraen-2-yl]propanimidic acid

C38H45N7O7 (711.338)